跳至主要内容
临床试验/NCT00167635
NCT00167635已完成2 期

Nursing Management of Irritable Bowel Syndrome: Improving Outcomes

University of Washington4 个研究点 分布在 1 个国家目标入组 188 人开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
188
试验地点
4
主要终点
Gastrointestinal symptoms

研究概览

简要总结

The purpose of this study is 1) to determine whether a comprehensive self-management intervention is effective in a sample that includes men and women with irritable bowel syndrome, and 2) to determine whether the comprehensive self-management intervention is as effective when delivered over the telephone as compared to a face-to-face approach.

详细描述

Randomization and Intervention Phase. Upon completing the baseline assessment phase, participants will be randomized to one of 3 treatment groups. A customized computer program will be used to do the randomization in an adaptive manner that ensures the 3 groups remain fairly balanced with respect to possible important predictors of outcomes: age, sex, predominant stool pattern (alternating, constipation-predominant or diarrhea-predominant), and severity of IBS symptoms and psychological symptoms at baseline. When each new participant is randomized, the program will adjust the probabilities of assignment to the three groups so that there is a higher probability of assignment to the group that results in the best balance.

Intervention Groups. Face-to-Face Individualized Comprehensive Self-Management (CSM-FF) Group. Participants in the individualized CSM-FF group will be scheduled for 9 weekly sessions with the nurse therapist followed by post-intervention follow-up assessment.

Telephone Individualized Comprehensive Self-Management (CSM-TEL) Group. Participants in the individualized CSM-TEL group will initially have 2 face-to-face meetings with the nurse therapist, 6 sessions over the phone and the final session face-to-face at 9 weeks.

Usual Care Control Group (UC). Following randomization the participants in the control group will no receive any contacts during the comparable 9-week intervention in the treatment groups.

Follow-up Phase. Participants in all 3 groups will be reassessed at 3-mo, 6-mo, and 12-mo post randomization. At this time the participants will complete questionnaires, a 4 week diary and collect 4 urines.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Irritable Bowel Syndrome

排除标准

  • GI pathology (organic disease)
  • Co-morbid pain disorders

结局指标

主要结局

Gastrointestinal symptoms

时间窗: baseline, and 3 months, 6 months, 12 months post randomization

Psychological distress

时间窗: baseline, and 3 months, 6 months, 12 months post randomization

Cognitive Scale for Functional Bowel Disorders (CFBD) describes 25 cognitive beliefs related to functional bowel disorders.

时间窗: baseline, and 3 months, 6 months, 12 months post randomization

Health Related Quality Of Life (HRQOL) will be measures with the Disease Specific Questionnaire-IBS (IBS-DSQ), a 42-item questionnaire.

时间窗: baseline, and 3 months, 6 months, 12 months post randomization

次要结局

  • Sleep disturbance(baseline, and 3 months, 6 months, 12 months post randomization)
  • Sexual dysfunction(baseline, and 3 months, 6 months, 12 months post randomization)
  • Catecholamine and cortisol levels (urine)(baseline, and 3 months, 6 months, 12 months post randomization)
  • Stool frequency/consistency(baseline, and 3 months, 6 months, 12 months post randomization)
  • Health care utilization(baseline, and 3 months, 6 months, 12 months post randomization)

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验